French diagnostics specialist BioMerieux (BIOX.PA) will look at the microbiology unit Siemens (SIEGn.DE) is considering selling, BioMerieux’s Chief Executive told Reuters. Sources have told Reuters Siemens may sell the business, which makes tools to detect bacteria and test antibiotics and is part of its diagnostics division, and that bankers are pitching it to likely buyers at around $500 million. “There is a dossier available and we will look at it closely,” CEO Jean-Luc Belingard told Reuters in an interview.
Help employers find you! Check out all the jobs and post your resume.
